Biora Therapeutics Shares Preclinical Data on Oral Delivery of Biologics at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
globenewswire.com
news
2022-10-19 00:00:00

SAN DIEGO, Oct. 19, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today shared a poster presented at the Parenteral Drug Association (PDA) Universe of Pre-Filled Syringes and Injection Devices Conference. The meeting in Palm Springs, California, October 18-19, 2022 explored the latest technological advances with drug delivery devices. 'Our platform is the first designed to use submucosal liquid jet injection to the small intestine for oral delivery of large molecules,' said Sharat Singh, PhD, Head of Research at Biora Therapeutics.
